Position in MRK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$296,643,534
+$29,469,220 QoQ
Shares Held
2,308,510
+3.9% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#103
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 3%
None 37%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Derivatives in MRK
reported options exposure · as of Sep 30, 2020CallValue
$1,177,890
CallShares
14,882
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUIST FINANCIAL CORP holds $2,652,531,465 across 15 Drug Manufacturers - General names. MRK ranks #4 (11.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
2,519,569 | $634,024,342 | |
| 2 | JNJ |
Johnson & Johnson
|
2,173,861 | $552,095,477 | |
| 3 | LLY |
ELI LILLY & Co
|
400,653 | $480,555,266 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
2,308,510 | $296,643,534 | |
| 5 | NVS |
Novartis AG
|
968,701 | $151,814,820 | |
| 6 | AZN |
Astrazeneca PLC
|
797,497 | $151,221,380 | |
| 7 | AMGN |
Amgen Inc
|
394,190 | $142,744,081 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,277,343 | $73,600,502 |
All Filings in MRK
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $296,643,534 | 2,308,510 | Shares | Defined | 2026-07-28 | |
| 2026-03-31 | $267,174,314 | 2,221,085 | Shares | Defined | 2026-04-27 | |
| 2025-12-31 | $215,658,898 | 2,048,821 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $138,748,206 | 1,653,142 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $141,990,478 | 1,793,715 | Shares | Defined | 2025-07-18 | |
| 2025-03-31 | $191,750,697 | 2,136,260 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $333,039,242 | 3,347,801 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $393,007,879 | 3,460,795 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $465,877,102 | 3,763,143 | Shares | Defined | 2024-08-21 | |
| 2024-03-31 | $494,198,403 | 3,745,346 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $411,149,740 | 3,771,324 | Shares | Defined | 2024-02-02 | |
| 2023-09-30 | $418,058,225 | 4,060,789 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $460,131,354 | 3,987,619 | Shares | Defined | 2023-08-01 | |
| 2023-03-31 | $527,313,416 | 4,956,419 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $571,971,325 | 5,155,217 | Shares | Defined | 2023-02-17 | |
| 2022-09-30 | $451,410,380 | 5,241,644 | Shares | Defined | 2022-10-26 | |
| 2022-06-30 | $470,147,095 | 5,156,818 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $426,895,399 | 5,202,869 | Shares | Defined | 2022-04-22 | |
| 2021-12-31 | $392,347,135 | 5,119,352 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $390,577,480 | 5,200,073 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $407,703,779 | 5,242,430 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $400,273,619 | 5,192,287 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $387,157,015 | 4,732,973 | Shares | Defined | 2021-11-19 | |
| 2020-09-30 | $1,177,890 | 14,200 | Call | Defined | 2021-11-05 | |
| 2020-09-30 | $383,178,078 | 4,619,384 | Shares | Defined | 2021-11-05 | |
| 2020-06-30 | $379,856,025 | 4,912,141 | Shares | Defined | 2021-11-16 | |
| 2020-03-31 | $367,475,055 | 4,776,127 | Shares | Defined | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||